摘要:
The present invention relates to a preventive or therapeutic agent for a glomerular disease which comprises an anti-thrombocytic agent and an HMG-CoA reductase inhibitor as active ingredients. The above agent is useful for prevention and therapy of various glomerular diseases including chronic glomerular nephritis.
摘要:
PROBLEM TO BE SOLVED: To provide a production intermediate of a tetracyclic derivative which is a selective inhibitor of the cyclic guanosine 3'5'-monophosphoric acid-specific phosphodiesterase (cGMP-specific PDE). SOLUTION: The production intermediate is a compound represented by formula (I). COPYRIGHT: (C)2009,JPO&INPIT
摘要:
PROBLEM TO BE SOLVED: To provide an intermediate for producing tetracyclic derivatives of a selective inhibiter for cyclic guanosine-3',5'-monophosphate specific phosphodiesterase (cGMP specific PDE). SOLUTION: The tetracyclic derivatives are represented by formula (I). The intermediates for producing the tetracyclic derivatives are represented by formula (II) or the like. COPYRIGHT: (C)2004,JPO&NCIPI
摘要:
PROBLEM TO BE SOLVED: To treat anal disease and pain accompanying with it easily. SOLUTION: This composition is suitable for the administration of an NO- donor to a zone where conventionally its administration is avoided. In order to achieve this and associated purposes, the effective medicinal composition useful for the treatment of the anal disease containing a carrier, optionally a corticosteroid and/or local anesthetic agent together with an organic NO-donor without having a weakening adverse effect is provided in one aspect. In one practicing embodiment, the method for treating the anal disease is to bring an effective amount of NO, preferably the NO delivered by the release from the organic NO-donor, in contact with the suitable anal part. COPYRIGHT: (C)2003,JPO
摘要:
NEW MATERIAL:A 3-propionylsalicyclic acid derivative of formula I [R is H, lower alkyl or formula II (R 1 and R 2 are lower alkyl or R 1 and R 2 together with the nitrogen atom to which they are linked through or not through a hetero atom may form a heterocyclic ring; n is an integer 1W4); X is H or halogen, provided that R represents formula II when X is H atom]. EXAMPLE: Ethyl-5-chloro-3-propionylsalicylate. USE: Useful as a remedy for preventing the fit of angina pectoris and cardiac infraction, etc. and a remedy for increasing the discharge capacity of the urinary bladder, disappearance of subjective symptom of thamuria, etc. having coronary arterial vasodilator action and coronary blood stream increasing action, and further useful as a synthetic intermediate for compounds useful as a diuretic having the remissive action, e.g. smooth muscle spasm in the lower urinary tract. PROCESS: A compound of formula III (X' is halogen) is reacted with a propionyl halide by the Friedel-Crafts reaction to give the aimed compound of formula I . COPYRIGHT: (C)1984,JPO&Japio
摘要:
NEW MATERIAL:The nitrogen-containing polycyclic compound of formula I (R 1 is lower alkyl; R 2 is aryl) and its salt. EXAMPLE: 16-Benzylidene-17-oxo-eburnane. USE: Vasodilator, antispasmodic agent and cerebral metabolism activating agent useful as a remedy for arteriosclerosis caused by thrombosis, etc. and cerebral and coronary vessel disorder. PROCESS: The compound of formula I is prepared by reacting the ketone derivative of formula II with the aldehyde derivative of formula R 2 -CHO in a proper solvent (e.g. alcoholic solvent, hydrated alcohol solvent, amide solvent, ether solvent, or aromatic hydrocarbon) in the presence of a base (e.g. metal hydride such as sodium hydride, caustic alkali, alkali metal carbonate, triethylamine, etc.). COPYRIGHT: (C)1982,JPO&Japio